Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery

NCT03375996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-08-22

No results posted yet for this study

Summary

Laser-assisted cataract surgery is an innovative and growing procedure to improve the safety and results of modern cataract surgery. However, this technique faces to some obstacles: economics in the one hand due to the cost and time spent for the laser procedure before the conventional surgery, and technical in the other hand, especially due to some loss of pupil dilation during the surgery, which is highly important to ensure a perfect procedure. The present study aims at assessing a pharmacological protocol to maintain an accurate pupil dilation all along the surgery in order to improve the whole procedure.

Conditions

  • Cataract Surgery

Interventions

DRUG

cyclopentolate 0.5% eye drops

cyclopentolate 0.5% eye drops and measurement of the pupillary mydriasis (dilatation)

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2024-08-21
Completion
2024-08-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375996 on ClinicalTrials.gov